Skip to main content

Q2 earnings

By Mallory Hackett | 01:44 pm | July 31, 2020
Dexcom President and CEO Kevin Sayer is “incredibly proud” of what the company is calling “resilient growth” in the second quarter of 2020, according to an earnings call on Tuesday.
By Dave Muoio | 02:29 pm | July 30, 2020
Although the company's rapid growth has been fueled by COVID-19, new contracts and state-by-state trends have CEO Jason Gorevic confident that telehealth adoption is here to stay.
By Dave Muoio and Jonah Comstock | 04:06 pm | May 01, 2019
Also: uBiome's FBI investigation; Better Therapeutics' pivotal trial plans.